Comparative studies of glycoprotein Ib in heparin coated and nonheparin coated extracorporeal circulation circuits

被引:1
|
作者
Hioki, I
Yada, I
Nishikawa, M
Shomura, Y
Cruz, BP
Onoda, K
Tani, K
Shimono, T
Shinpo, H
机构
[1] Mie Univ, Sch Med, Dept Thorac & Cardiovasc Surg, Tsu, Mie 5148507, Japan
[2] Mie Univ, Sch Med, Dept Internal Med 2, Tsu, Mie 5148507, Japan
关键词
D O I
10.1097/00002480-199809000-00014
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Contact between blood and artificial materials has various effects on blood. Impairment of platelet function is an especially important and well known effect, but its precise mechanism is not clearly understood. The authors constructed a circulation model to investigate the effect of extracorporeal circulation on platelet membrane glycoproteins (CPs), especially GP Ib, and to compare the changes in CP Ib in heparin coated (group C) and nonheparin coated (group N) circuits. As determined by flow cytometry, CP Ib in both groups decreased on initiating circulation, but the decrease in group N was significantly larger than that in group C. There was no observed change in GP IIb/IIIa levels in either group. The extent of shear stress induced platelet aggregation significantly decreased during circulation in both groups. Decreases in the extent of shear stress induced platelet aggregation were significantly less with the use of heparin coated circuits. In addition, the amount of CP Ib in the high speed pellet decreased progressively during circulation in both groups. In contrast, the amount of GP Ib in the Triton insoluble (low speed) pellet increased dramatically during circulation. However, expression of CP Ib in the Triton soluble platelet fraction was low in both groups. From the results, it was concluded that the cause of the decrease in platelet function during extracorporeal circulation is attributable to the internalization of CP Ib from the platelet surface inside the platelet. It also can be said that a heparin coated circuit is one effective means of controlling this change.
引用
收藏
页码:M397 / M400
页数:4
相关论文
共 50 条
  • [41] The effects of heparin coated circuits on pulmonary injury -: A clinical study
    Kazaz, H
    Oto, Ö
    Sariosmanoglu, N
    Hazan, E
    JOURNAL OF CARDIOVASCULAR SURGERY, 2003, 44 (05): : 611 - 615
  • [42] HEPARIN-COATED BYPASS CIRCUITS REDUCE PULMONARY INJURY
    REDMOND, JM
    GILLINOV, AM
    STUART, RS
    ZEHR, KJ
    WINKELSTEIN, JA
    HERSKOWITZ, A
    CAMERON, DE
    BAUMGARTNER, WA
    ANNALS OF THORACIC SURGERY, 1993, 56 (03): : 474 - 479
  • [43] Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations
    Ovrum, E
    Tangen, G
    Oystese, R
    Ringdal, MAL
    Istad, R
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 121 (02): : 324 - 330
  • [44] POSSIBLE INTERACTION OF CORPUSCULAR AND PLASMATIC BLOOD COMPONENTS WITH HEPARIN-COATED ARTIFICIAL DEVICES DURING EXTRACORPOREAL-CIRCULATION
    HELLER, W
    WENDEL, HP
    KLAFFSCHENKEL, R
    HOFFMEISTER, HE
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 937 - 937
  • [45] EXTRACORPOREAL CO2-REMOVAL WITH A HEPARIN COATED ARTIFICIAL LUNG
    PETERS, J
    RADERMACHER, P
    KUNTZ, ME
    ROSENBAUER, KA
    BREULMANN, M
    BURRIG, KF
    HOPF, HB
    ROSSAINT, R
    SCHULTE, HD
    OLSSON, P
    FALKE, KJ
    INTENSIVE CARE MEDICINE, 1988, 14 (05) : 578 - 584
  • [46] Adsorption of inflammatory cytokines using a heparin-coated extracorporeal circuit
    Fujita, M
    Ishihara, M
    Ono, K
    Hattori, H
    Kurita, A
    Shimizu, M
    Mitsumaru, A
    Segawa, D
    Hinokiyama, K
    Kusama, Y
    Kikuchi, M
    Maehara, T
    ARTIFICIAL ORGANS, 2002, 26 (12) : 1020 - 1025
  • [47] Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits
    Kutay, Veysel
    Noyan, Tevfik
    Ozcan, Sedat
    Melek, Yasin
    Ekim, Hasan
    Yakut, Cevat
    JOURNAL OF CARDIAC SURGERY, 2006, 21 (06) : 572 - 577
  • [48] Evaluation of blood components exposed to coated arterial filters in extracorporeal circuits
    Hussaini, Bader E.
    Treanor, Patrick R.
    Healey, Nancy A.
    Tilahun, Daniel
    Srey, Rithy
    Lu, Xiu-Gui
    Khuri, Shukri F.
    Thatte, Hemant S.
    PERFUSION-UK, 2009, 24 (05): : 317 - 323
  • [49] Heparin-coated bypass circuits in cardiopulmonary bypass: Improved biocompatibility or not
    Levy, M
    Hartman, AR
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1996, 53 : S81 - S87
  • [50] Heparin coated bypass circuits Carmeda(R) prevent the activation of fibrinolysis
    Spiess, BD
    Vocelka, C
    Cochran, RP
    Soltow, L
    Chandler, WL
    ANESTHESIA AND ANALGESIA, 1996, 82 (04): : SCA6 - SCA6